ÂÜÀòÂÒÂ×

Ken Horne is currently the Managing Partner at AN Venture Partners, CEO at Typewriter Therapeutics, Inc., and CEO at Capacity Bio. With a background in Biomechanical Engineering and Computer Science from Stanford University, Ken has held various advisory and leadership positions in multiple biotech companies such as Viage Therapeutics, Inc., Teon Therapeutics Inc., and Preferred Medicine, Inc. Ken has also served as an advisor at Kicker Ventures and Advantary LLC. A notable achievement includes leading the company creation for Remiges Ventures and establishing cross-border biotech companies from the US.